Bridges4Kids Logo

 
About Us Breaking News Find Help in Michigan Find Help in the USA Find Help in Canada Inspiration
IEP Goals Help4Parents Disability Info Homeschooling College/Financial Aid Summer Camp
IEP Topics Help4Teachers Homework Help Charter/Private Insurance Nutrition
Ask the Attorney Become an Advocate Children "At-Risk" Bullying Legal Research Lead Poisoning
 
Bridges4Kids is now on Facebook. Follow us today!
 

 

 Article of Interest - Assistive Technology

MD Step-climbing wheelchair clears panel
from the Atlanta Journal-Constitution, November 22, 2002
For more articles visit www.bridges4kids.org


Stairs soon may no longer be insurmountable obstacles for some of the nation's 2 million wheelchair users.

The first wheelchair that can climb stairs -- plus shift into four-wheel drive to scoot up a grassy hill and even elevate its occupant for eye-level conversation -- took a major step toward the market Wednesday, as advisers to the Food and Drug Administration unanimously recommended it be allowed to sell.

But the panel backed a few limitations on the Independence iBOT 3000 Mobility System -- which uses sensors and gyroscopes to balance on two wheels and navigate stairs -- including that it be sold only with a
doctor's prescription and that users undergo strict training to ensure they can drive it safely.

The FDA isn't bound by its advisers' recommendations, but usually follows them -- and it granted the iBOT a special fast-track review reserved for important new technology, meaning a decision could come in a few months.

How does it climb? Most wheelchairs have two big back wheels and two smaller front wheels. The iBOT has four wheels the same size that rotate up and over one another to go up and down steps.

Well-known inventor Dean Kamen created the iBOT, and he says wheelchair users tell him another feature is as appealing: The chair lifts onto two wheels so that its occupant, although still sitting, is elevated enough to
reach high bookshelves and carry on eye-level conversations with people standing nearby.

"One reason I built it was to let people stand up," said Kamen, who licensed the iBOT to Johnson & Johnson. "We treat a lot of adults like children because they can't stand up."

"I wanted to take it home and keep it," said Karl Barnard of Tilton, N.H., who tested the iBOT in a study required by the FDA, which regulates wheelchair safety.

In the iBOT, he rose to the height of a 6-foot-tall person to do his grocery shopping without help. Barnard, who lost use of his legs 25 years ago, has no stairs in his home, but was impressed with the four-wheel
drive, which let him roll up hills and through gravel on his farm, places his manual wheelchair can't go.

But with a predicted $29,000 price tag, Barnard, 46, calls it "more a luxury item" that he probably wouldn't buy until he's too old to push his manual wheelchair easily.

While several FDA advisers called the chair potentially revolutionary, they also cautioned it's not for everyone.

Patients must have the use of at least one arm to operate the chair, moving it with a joystick and other controls, and so far it's built only for large teenagers and adults.

Also, it requires some exertion: Users lean forward or backward, directing the chair to climb up or down as it senses and adjusts to the person's center of gravity. They must hold onto a stair rail to help guide it, although there is a feature that allows someone else to hold onto the chair back and assist the more severely disabled on stairs.

Picking the right patient is crucial for safe use -- someone who not only is physically capable of handling the iBOT, but has the right judgment skills to discern obstacles, such as which hills are too steep to climb
without risking serious falls, said Dr. Steve Stiens, a University of Washington rehabilitation specialist who uses a wheelchair.

Sales will be strictly controlled, said manufacturer Independence Technology, a Johnson & Johnson subsidiary. Doctors and rehabilitation therapists must undergo special training to prescribe the iBOT, and
potential users would have to pass a test proving they can drive it safely before taking it home.

To prove iBOT works, 20 wheelchair users test-drove it for two weeks, allowing scientists to compare maneuverability, falls or other problems to their regular wheelchairs. They also took a road test, scooting up hills and over bumpy sidewalks, crossing curbs, reaching shelves and climbing stairs.

The patients performed most of the challenges more easily with the iBOT, said study leader Dr. Heikki Uustal of New Jersey's Johnson Rehabilitation Institute. For example, everyone had to ask for help to reach a book atop a bookcase while in their own chairs, but merely pushed a button on the iBOT to slowly rise and reach it themselves.

Twelve patients could navigate stairs alone with the iBOT, while the rest used an assistant. In regular wheelchairs, two patients could literally bump their way down stairs, but no one could go up a single step.

Three people fell out of the iBOT and two fell out of their own wheelchairs during the study, suggesting the iBOT is as safe as today's technology.

The iBOT's $29,000 tab is less than some top-of-the-line models for the severely impaired, but far more than basic chairs. But Independence Technology President Jean-Luc Butel said the average cost for ramps,
elevators and other home modifications for someone unable to walk is $40,000, expenditures largely unnecessary with the iBOT. He is negotiating with Medicare and other insurers to pay for the iBOT.

 

Thank you for visiting https://www.bridges4kids.org/.

 

bridges4kids does not necessarily agree with the content or subject matter of all articles nor do we endorse any specific argument.  Direct any comments on articles to deb@bridges4kids.org.  

 

© 2002-2021 Bridges4Kids

 

NOTE: (ALL RESOURCES PRE-IDEA 2004 ARE FOR INFORMATIONAL/HISTORICAL RESEARCH PURPOSES ONLY)